Ginkgo Bioworks Holdings, Inc.

Ownership Transactions Reported by 19 Insiders

Symbol
DNA on NYSE, DNABW on OTC
Industry
Biological Products, (No Diagnostic Substances)
Location
27 Drydock Avenue, 8 Th Floor, Boston, MA

Insiders trading volume in the past year

Ginkgo Bioworks Holdings, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Barry Canton 10%+ Owner $323M Apr 25, 2024
Reshma P. Shetty President, COO & Founder, Director, 10%+ Owner $323M Apr 25, 2024
Cascade Investment, L.L.C. 10%+ Owner $236M Sep 16, 2021
Viking Global Investors Lp 10%+ Owner $79.4M Mar 2, 2022
Eagle Equity Partners III, LLC Director, *Director by Deputization, 10%+ Owner $49.1M Sep 16, 2021
Jason R. Kelly CEO & Founder, Director $6.06M Apr 25, 2024
Marijn E. Dekkers Director $3.24M -$1.83M -36% Jun 12, 2024
Harry Sloan Director $2.75M +$272K +11% Dec 11, 2024
Shyam Sankar Director $1.59M +$515K +47.9% Jun 12, 2024
Christian Henry Director $973K Jun 12, 2024
Marie E. Fallon Chief Accounting Officer $672K May 1, 2023
Arie Belldegrun Director $619K Jun 12, 2024
Mark E. Dmytruk Chief Financial Officer $420K -$152K -26.7% Mar 13, 2025
Kathy Hopinkah Hannan Director $329K Jun 12, 2024
Ross Fubini Director $238K Jun 13, 2024
Myrtle S. Potter Director $238K Jun 13, 2024
Sri Kosuri Director $182K Nov 6, 2024
Reshma Kewalramani Director $102K Jun 12, 2024
Steven P. Coen Chief Accounting Officer $94.7K -$148K -61% Mar 6, 2025

Recent Insider Transactions by Companies or Individuals for Ginkgo Bioworks Holdings, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.